Review Article

An assessment of antiretroviral drug initiation to pregnant women of unknown HIV status during labour and delivery in Cameroon

Published in: African Journal of AIDS Research
Volume 17 , issue 3, pages: 265–271
DOI: 10.2989/16085906.2018.1515780
Author(s): Anastasia Yenban BongajumMinistry of Public Health, Cameroon, Divine Mbiydzenyuy DufeMerck Animal Health, The Netherlands, Paul Théodore Biyaga TjekMinistry of Public Health, Cameroon, Daniel Ter GoonDepartment of Nursing Sciences, , Céline Nguefeu Nkenfou“Chantal Biya” Reference Centre for HIV/AIDS Prevention and Management, Cameroon, Julius Mbekem NwobegahayCameroon Military Health Research Center (CRESAR), Cameroon, Robinson MbuDepartment of Family Health, Ministry of Public Health, Cameroon,

Abstract

Background: Evidence from previous research has shown that antiretroviral (ARV) drug initiation to seropositive pregnant women could significantly contribute to eliminating new paediatric infections even when started during labour and delivery. This study therefore seeks to assess missed opportunities for ARV initiation during this critical period of pregnancy to improve outcomes of the prevention of mother-to-child transmission (PMTCT) programmes in Cameroon.

Get new issue alerts for African Journal of AIDS Research